Regimens combining radiation and immunotherapy for cancer: latest updates from 2024 ASCO Annual Meeting

2024-9-13

c-Myc alone is enough to reprogram fibroblasts into functional macrophages

2024-9-12

Outcome after short exposure to tyrosine kinase inhibitors in pregnant female patients with chronic myeloid leukemia

2024-9-11

Heat shock proteins as hallmarks of cancer: insights from molecular mechanisms to therapeutic strategies

2024-9-4

Novel potent molecular glue degraders against broad range of hematological cancer cell lines via multiple neosubstrates degradation

2024-9-2

Reduced-dose chemotherapy and blinatumomab as induction treatment for newly diagnosed Ph-negative B-cell precursor acute lymphoblastic leukemia: a phase 2 trial

2024-9-2

Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution

2024-9-2

METTL16-SENP3-LTF axis confers ferroptosis resistance and facilitates tumorigenesis in hepatocellular carcinoma

2024-9-2

New strategies in soft tissue sarcoma treatment

2024-9-2

Correction: Mature B, T and NK-cell, plasma cell and histiocytic/dendritic cell neoplasms: classification according to the World Health Organization and International Consensus Classification

2024-8-29

Global burden of thyroid cancer from 1990 to 2021: a systematic analysis from the Global Burden of Disease Study 2021

2024-8-27

Targeting Claudin-18.2 for cancer therapy: updates from 2024 ASCO annual meeting

2024-8-26

Spatial multi-omics: deciphering technological landscape of integration of multi-omics and its applications

2024-8-24

A single-cell and spatially resolved atlas of human osteosarcomas

2024-8-20

Genomic characterization of AML with aberrations of chromosome 7: a multinational cohort of 519 patients

2024-8-19

Targeting cuproptosis for cancer therapy: mechanistic insights and clinical perspectives

2024-8-16

Comparisons of treatment outcomes of epcoritamab versus chemoimmunotherapy, polatuzumab-based regimens, tafasitamab-based regimens, or chimeric antigen receptor T-cell therapy, in third-line or later relapsed/refractory large B-cell lymphoma

2024-8-16

IL1RAP-specific T cell engager depletes acute myeloid leukemia stem cells

2024-8-14

LncRNA-encoded peptides in cancer

2024-8-12

Correction: lncRNA SNHG6 regulates EZH2 expression by sponging miR-26a/b and miR-214 in colorectal cancer

2024-8-9

Recent developments in immunotherapy for gastrointestinal tract cancers

2024-8-9

Overcome the challenge for intratumoral injection of STING agonist for pancreatic cancer by systemic administration

2024-8-7

Prevalence of fungal DNAemia mediated by putatively non-pathogenic fungi in immunocompromised patients with febrile neutropenia: a prospective cohort study

2024-8-7

Continuous therapy in HHV-8 negative Multicentric Castleman Disease and prolonged progression-free survival

2024-8-6

Novel prognostic scoring systems for severe CRS and ICANS after anti-CD19 CAR T cells in large B-cell lymphoma

2024-8-6

Retraction Note: AMLnet, A deep-learning pipeline for the differential diagnosis of acute myeloid leukemia from bone marrow smears

2024-8-1

SMARCA4 controls state plasticity in small cell lung cancer through regulation of neuroendocrine transcription factors and REST splicing

2024-7-30

A practical approach on the classifications of myeloid neoplasms and acute leukemia: WHO and ICC

2024-7-29

Novel natural killer cell-based therapies for hematologic and solid malignancies: latest updates from ASCO 2024

2024-7-29

Harnessing extracellular vesicles using liquid biopsy for cancer diagnosis and monitoring: highlights from AACR Annual Meeting 2024

2024-7-29

Dual blockade immunotherapy targeting PD-1/PD-L1 and CTLA-4 in lung cancer

2024-7-27

Lipid-based nanosystems: the next generation of cancer immune therapy

2024-7-19

Menin inhibitors for acute myeloid leukemia: latest updates from the 2023 ASH Annual Meeting

2024-7-19

Mature B, T and NK-cell, plasma cell and histiocytic/dendritic cell neoplasms: classification according to the World Health Organization and International Consensus Classification

2024-7-8

Memory T-cell enriched haploidentical transplantation with NK cell addback results in promising long-term outcomes: a phase II trial

2024-6-27

Individualized dynamic frailty-tailored therapy (DynaFiT) in elderly patients with newly diagnosed multiple myeloma: a prospective study

2024-6-24

Advances in CAR-T-cell therapy in T-cell malignancies

2024-6-24

Wnt/β-catenin signaling pathway in carcinogenesis and cancer therapy

2024-6-18

Remodeling of anti-tumor immunity with antibodies targeting a p53 mutant

2024-6-18

Non-invasive diagnosis of esophageal cancer by a simplified circulating cell-free DNA methylation assay targeting OTOP2 and KCNA3: a double-blinded, multicenter, prospective study

2024-6-18

Deciphering the performance of macrophages in tumour microenvironment: a call for precision immunotherapy

2024-6-11

Neutrophil-specific expression of JAK2-V617F or CALRmut induces distinct inflammatory profiles in myeloproliferative neoplasia

2024-6-9

Impact of extramedullary multiple myeloma on outcomes with idecabtagene vicleucel

2024-6-6

Ferroptosis: principles and significance in health and disease

2024-6-6

Current and future immunotherapeutic approaches in pancreatic cancer treatment

2024-6-4

Targeting FGFR for cancer therapy

2024-6-3

Novel clinical risk stratification and treatment strategies in relapsed/refractory peripheral T-cell lymphoma

2024-6-1

Advances in targeting histone deacetylase for treatment of solid tumors

2024-5-31

Identification of restrictive molecules involved in oncolytic virotherapy using genome-wide CRISPR screening

2024-5-23

PD-1 blockade immunotherapy as a successful rescue treatment for disseminated adenovirus infection after allogeneic hematopoietic stem cell transplantation

2024-5-20